Aditxt, Inc. (ADTX) stock: key figures, P/E, revenue and dividend
Health Care · United States · ISIN US0070251097
Aditxt, Inc. financials
| Fiscal year | 2025 |
|---|---|
| Revenue | 3,195.00 USD |
| Gross profit | 268.00 USD |
| Operating income | -19.57 m USD |
| EBIT | -43.69 m USD |
| Net income | -43.10 m USD |
| Diluted EPS – continuing operations | -1,153.83 USD |
Full history since 2017, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Aditxt, Inc.
Aditxt, Inc. focuses on discovery and development of biopharmaceutical products. The company develops AditxtScore and FlowSpot that enable individuals to understand, manage, and monitor their immune profiles in order to be informed about attacks on or by their immune system; and Apoptotic DNA Immunotherapy, a nucleic acid-based technology that utilizes an approach that mimics the way the body naturally induces tolerance to its tissues. It develops ADI-100 for skin grafting, psoriasis, and type-1 diabetes. In addition, the company provides Pearsanta that develops molecular tests based on the mitochondrial DNA (mtDNA) to develop tests for early detection of cancer; Mitomic targets mutations in mitochondrial DNA (mtDNA) to detect disease; Mitomic prostate test a blood-based assay that quantifies the level of the 3.4kb mtDNA deletion; and Mitomic endometriosis test, a blood-based assay that quantifies the level of one or more mtDNA deletions. Further, it offers Adivir for commercial development of products to address significant unmet needs in infectious disease and population health; and Adifem address critical unmet needs in women health. The company has a license agreement with Loma Linda University and Leland Stanford Junior University. The company was formerly known as ADiTx Therapeutics, Inc. and changed its name to Aditxt, Inc. in July 2021. Aditxt, Inc. was incorporated in 2017 and is headquartered in Mountain View, California.
More stocks
- Tenon Medical, Inc. (TNON)
- CYABRA, INC. (CYAB)
- AMERICAN REBEL HOLDINGS INC (AREB)
- MSP Recovery, Inc. (MSPR)
- QVC Group, Inc. (QVCG)
- CDT Equity Inc. (CDT)
- RYAN SPECIALTY HOLDINGS, INC. (RYAN)
- Legence Corp. (LGN)
- PJT Partners Inc. (PJT)
- Hamilton Lane INC (HLNE)
- Andersen Group Inc. (ANDG)
- Cactus, Inc. (WHD)
Not investment advice. All data without warranty, price as of 28.10.2026. Details in the risk notice.